Intercept Pharma Soars 33% On Advanz Pharma Deal for Non-US Expansion
(Intercept Pharma) Shares of Intercept Pharmaceuticals rose 33% on Thursday after inking a deal with Advanz Pharma to commercialize its drug Ocaliva® for PBC outside of the US. Under the…